Document:

Exhibit
10.1

EMPLOYMENT
AGREEMENT BETWEEN

REGEN
BIOPHARMA, INC.

AND

TODD
S. CAVEN

 

THIS EMPLOYMENT
AGREEMENT (the "Agreement") dated as of February 11, 2015 is entered into between Regen BioPharma,
Inc., a Nevada corporation, (the "Company") and Todd S. Caven ("Employee").

 

WITNESSETH:

WHEREAS, Employee
and the Company desire to enter into an agreement providing for the employment by the Company of Employee
upon the terms provided herein.

REPRESENTATIONS AND WARRANTIES

 

A)
Company hereby represents and warrants to Employee as follows;

(i)
Corporate Existence of Company. Company:

(a)
is a corporation duly formed, validly existing and in good standing under the laws of the State of Nevada and

(b)
has all requisite power and authority, and has all governmental licenses, authorizations, consents and approvals necessary to
execute and deliver this Agreement and to consummate the transactions contemplated by this Agreement.

 

(ii) No
Conflicts. None of the execution, delivery and performance of this Agreement by Company, or the consummation
or the transactions contemplated hereby and thereby

 

(a)
constitutes or will constitute a violation of the organizational documents of Company,

 

(b)
constitutes or will constitute a breach or violation of, or a default (or an event which, with notice
or lapse of time or both, would constitute such a default) under, any indenture, mortgage,
deed of Company, loan agreement, lease or other agreement or instrument to which Company is a
party or by which Company or any of its properties may be bound,

 

(c)
violates or will violate any statute, law or regulation or any order, judgment, decree or injunction of any court
or Governmental Authority directed to Company or any of its properties in a proceeding to which
its property is or was a party.

 

(B)
Employee hereby represents and warrant to Company as follows:

(i)
No Conflicts. None of the execution, delivery and performance of this Agreement by Employee, or the consummation of the transactions
contemplated hereby and thereby

(a)
constitutes or will constitute a breach or violation of, or a default (or an event which, with notice or lapse of time or both,
would constitute such a default) under, any indenture, mortgage, deed of Trust, loan agreement, lease or other agreement or instrument
to which Employee is a party or by which Employee or any of its properties may be bound,

(b)
violates or will violate any statute, law or regulation or any order, judgment, decree or injunction of any court or Governmental
Authority directed to Employee or any of their properties in a proceeding to which its property is or was a party.

AGREEMENT:

NOW,
THEREFORE, in consideration of the foregoing and the mutual promises and agreements set forth herein, the parties hereto, intending
to be legally bound, hereby agree as follows:

1.
Employment. During the Employment Period (as defined in Section 2), the Company hereby employs Employee and Employee hereby accepts
employment.

2.
Term. The Term of this Agreement shall commence on February 11, 2015 and shall expire on February 11, 2018 unless sooner terminated
in accordance with the provisions of Section 6 hereof; provided, however, that the term of this Agreement may be extended by mutual
agreement. The period from the commencement of the term of this Agreement to the date of its expiration or sooner termination
shall be considered to be the “Employment Period" hereunder.

3.
Duties. Employee shall be granted the title of Chief Financial Officer of the Company subject to the authority of the Company's
Chief Executive Officer (the “CEO”). Employee shall perform such duties commensurate with his office and as directed
the CEO such duties to include, but not be limited to:

See Schedule 1.

During the Employment
Period, Employee shall perform his duties hereunder in a diligent manner, subject to the provisions of Schedule 1 of this Agreement;
devoting such amount of his business time, attention and efforts to the affairs of the Company within the scope of his employment
as is necessary for the proper rendition of such service and shall use his best efforts to promote the best interests of the Company.
Employee's services shall be rendered when and as required by the Board and in accordance with his instructions, direction and
control.

It is agreed that Employee
will only devote such time as to effectively conduct duties and responsibilities associated with this position pursuant to this
Agreement.

4. Compensation
Salary.

 

During the Employment Period, Company shall pay Employee salary at the rate of (i) $13,500 per month prorated for
any partial employment month ("Salary"). Salary shall be paid on a monthly basis (“Payday”) or, in the event
that Payday falls on a Saturday, Sunday or holiday, on the next business day. Salary may be paid, at the Company’s sole
discretion, either in

 

(a)        cash,
or

(b)        shares
of the Company’s common stock (“Stock Payment”)

 

Employee acknowledges
that any Stock Payments issued pursuant to this Agreement that are not registered pursuant to the Securities Act of 1933
shall constitute “restricted securities” as that term is defined in Rule 144 promulgated under the Securities Act
of 1933, and shall contain the following restrictive legend:

 

THESE SECURITIES
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR SECURITIES LAWS OF ANY STATE
AND MAY NOT BE OFFERED, SOLD, ASSIGNED, PLEDGED, TRANSFERRED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION UNDER THE
ACT OR SUCH LAWS AND, IF REQUESTED BY THE COMPANY, UPON DELIVERY OF AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY
THAT THE PROPOSED TRANSFER IS EXEMPT FROM THE ACT OR SUCH LAWS.

 

The Company
may register any Stock Payment pursuant to the Securities Act of 1933, but is not obligated to do so pursuant to this Agreement.

 

5.
Benefits.

a.
During the Employment Period, Employee shall be entitled to participation in any profit sharing plan, retirement plan, group life
insurance plan or other insurance plan, medical expense plan, medical and dental insurance and other benefit arrangements maintained
by the Company for its employees generally and, if applicable, their family members. In addition, Employee shall be entitled to
two weeks paid vacation (“Vacation”) subject to (i) the completion of 12 full months of employment pursuant to this
Agreement and (ii) having given fourteen days prior notice to the Company of Employee’s intent to Vacation.

b.
Stock Compensation.  Employee shall receive 7,500,000 newly issued common shares of the Company upon execution of this agreement
(“Signing Shares”).  The shares shall be subject to a vesting schedule (See Schedule 2)

Employee
acknowledges that any Signing Shares  issued pursuant to this Agreement will not be  registered pursuant to the Securities
Act of 1933 , shall constitute “restricted securities” as that term is defined in Rule 144 promulgated under the Securities
Act of 1933 and shall contain the following restrictive legend:

THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR SECURITIES LAWS OF
ANY STATE AND MAY NOT BE OFFERED, SOLD, ASSIGNED, PLEDGED, TRANSFERRED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION
UNDER THE ACT OR SUCH LAWS AND, IF REQUESTED BY THE COMPANY, UPON DELIVERY OF AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO
THE COMPANY THAT THE PROPOSED TRANSFER IS EXEMPT FROM THE ACT OR SUCH LAWS.

6. Termination.

a.
Employee's employment hereunder shall terminate upon the earlier of:

(i)
the expiration of the Employment Period,

(ii)
the death of Employee,

(iii)
the expiration of a continuous period of thirty (30) calendar days during which Employee is unable to perform his material duties
due to physical or mental incapacity,

(iv)
termination by the Company due to “just cause,”

(v)
termination by Employee due to a material breach of this Agreement by the Company . The exercise of the right of the Company or
Employee to terminate this Agreement pursuant to clauses (iv) or (v) hereof, as the case may be, shall not abrogate the rights
and remedies of the terminating party in respect of the breach giving rise to such termination.

b.
"Just cause" hereunder shall be defined and limited to mean:

(i)
Employee's failure or refusal, as determined by either the CEO in his sole discretion, to perform specific directives of the CEO
which are consistent with the scope and nature of Employee's duties and responsibilities as set forth herein (including the duties
described in Section 3), which failure or refusal continues after notice thereof and a reasonable time to cure; such reasonable
time to be determined by the CEO.

(ii)
Employee's conviction for a felony or any crime involving moral turpitude, fraud, or misrepresentation, or the presentation of
proof satisfactory to the CEO in the exercise of his reasonable judgment of Employee's misappropriation or embezzlement of funds
or assets from the Company;

(iii)
any intentional act having the purpose and effect of injuring the reputation, business or business relationships of the Company
in any material respect; and

(iv)
any breach by Employee of any material provision of this Agreement, including, without limitation, the restrictive covenants contained
in Section 7 hereof.

c.
In the event of any dispute regarding the existence of Employee's incapacity hereunder, the matter wil1 be resolved by the determination
of a physician qualified to practice medicine in California selected by the CEO. For this purpose, Employee will submit to appropriate
medical examinations.

d.
If Employee's employment hereunder is terminated pursuant to Section 6, the Company shall have no further obligations or liabilities
hereunder.

7. Restrictive
Covenant.

a.
Non-disclosure. Employee has, and during the Employment Period will have, access to confidential information and trade secrets
of the Company and its subsidiaries (the "Confidential Information") that may include, among other things:

(i)
Financial information

(ii) Supply and services
information

(iii) Marketing information

(iv) Personnel information

(v) Customer information

(vi) Product information

(vii) The Company’s
procedures, systems, policies and processes of operation.

Employee
shall at all times during his employment by the Company and thereafter hold in strictest confidence any and all Confidential Information
that may have come or may come into Employee's possession or within Employee's knowledge. Employee agrees that neither he nor
any person or entity, directly or indirectly, controlled by or under common control with the Employee (an "Affiliate")will
for any reason, except in the course of performing his duties hereunder, for himself or any other person, use or disclose to anyone,
exclusive of Company employees, agents, representatives, or independent consultants to the Company or any of its subsidiaries
or Affiliates of the Company, any Confidential Information; provided, however, that Employee may disclose Confidential Information
which (i) has become generally available to the public other than as a result of a breach of this Agreement by Employee or (ii)
Employee is compelled to disclose pursuant to subpoena or an order by a court competent jurisdiction; provided that, if Employee
is so required to disclose any Confidential Information pursuant to the foregoing clause (ii), Employee shall provide advance
written notice to the Company, to the extent possible, to allow the Company to seek an appropriate protective order therefore
(iii) Potential advisors, employees, or investors of the Company where there is a reasonable expectation of confidentiality. All
Confidential Information shall remain the Company's property and shall be returned (or, at the Company's option, destroyed) upon
the Company's written request.

b.
Non-Solicitation of Employees. Employee agrees that from the date hereof and continuing for a period of three years following
the termination of this Agreement for whatever reason (the "Non-Compete Period"), neither Employee nor any Affiliate
of Employee will solicit or hire for employment any officer, director or employee of the Company who was employed by the Company
at any time within twelve months prior to the act of solicitation.

c.
Non-Competition. Employee agrees that, other than with the approval of the CEO, which approval shall not be unreasonably withheld,
during the Employment Period, neither Employee nor any Affiliate of Employee will, directly or indirectly, become a shareholder,
director, officer, agent, partner or employee of, or otherwise hold any ownership interest in, any person, firm or entity engaged
in any Competitive Business (as defined below), engage as a sole proprietor in any Competitive Business, act as a consultant to
or assist any of the foregoing or otherwise engage or participate in any Competitive Business; provided, however, that the foregoing
shall not prohibit the ownership by Employee of less than ten percent (10%) of the outstanding shares of the stock of any corporation
engaged in any Competitive Business, which shares are regularly traded on a national securities exchange or in any over-the-counter
market. For the purpose hereof, "Competitive Business" means the ownership, operation, development, marketing of the
services related to, or management of cellular therapeutics within the United States.

d.
Consideration, Relief, Reformation; Severability. The Company has specifically bargained for the covenants set forth in this Section
6 in consideration for the compensation, experience, and information that Employee will gain or receive in connection with his
employment by the Company. Employee agrees that the covenants set forth herein will not preclude Employee from engaging in any
lawful profession, trade or business or from being gainfully employed necessary to provide Employee, his family members and dependents
a standard of living to which he and they have been accustomed and may expect. Employee acknowledges and agrees that the restrictive
covenants in this Section 6 have been specifically negotiated, are reasonable in all respects, including, without limitation,
their geographic scope and duration, and may be enforced by specific performance or otherwise. Employee shall not raise any issue
of reasonableness as a defense in any proceeding to enforce any of such covenants. Notwithstanding the foregoing, in the event
that a covenant included in this Agreement shall be deemed by any court to be unreasonably broad in any respect, it shall be modified
or limited in its geographic scope, duration or otherwise to the extent necessary to make it reasonable while preserving its restrictive
nature to the maximum degree possible and shall be enforced accordingly; provided however, that if, notwithstanding the foregoing,
a court of competent jurisdiction shall hold any of the covenants contained in Sections 7 (a), (b) or (c) to be unenforceable
(as so modified), then the unenforceable covenant shall be deemed eliminated from the provisions of this Agreement for the purpose
of those proceedings to the extent necessary to permit the remaining covenants to be enforced so that the validity, legality or
enforceability of the remaining provisions of this Agreement shall not be affected thereby.

8. Developments.

Employee
hereby assigns to the Company his entire right, title and interest in all know how, discoveries and improvements,
customer lists, trade secrets and ideas, writings and copyrightable material, which may be conceived by Employee
or developed or acquired by him during the term of this Agreement, which may pertain directly to the Company's business
and were developed with Company resources. Employee agrees to promptly and fully disclose in writing all such developments. Employee
will, upon the Company's request, execute, acknowledge and deliver to the Company all instruments
and do all other acts which are necessary or desirable to entitle the Company to all rights in the foregoing
and enable the Company to file and prosecute applications for, and to acquire, maintain and enforce all letters, trademark
registrations or copyrights with respect to the foregoing in all countries.

9. Remedies.

Employee
acknowledges that any material breach of this Agreement will cause irreparable harm to the Company, that such harm will be difficult
if not impossible to ascertain, and that the Company shall be entitled to equitable relief, including injunction, against
any actual or threatened breach hereof, without bond and without liability should such relief be denied, modified or vacated.
Neither the right to obtain such relief nor the obtaining of such relief shall be exclusive of or preclude the
Company from any other remedy.

10.
Legal Counsel.

Employee
acknowledges that Employee has carefully read this Agreement and understands all of the terms hereof and that Employee
has been given the opportunity to discuss this Agreement with Employee's private legal counsel and
has availed himself of that opportunity to the extent Employee wishes to do so.

11. Notices.

All
notices, requests and other communications under this Agreement shall be in writing and shall be deemed to have been received
five business days after having been deposited in the United States Mail and enclosed in a registered or certified post-paid
envelope; one day after having been sent by overnight courier on a business day or otherwise at the open of
business on the next succeeding business day; when personally delivered or sent by facsimile communications equipment
of the sending party on a business day or otherwise at the open of business on the next succeeding business day; and, in
each case, addressed to the respective parties at the addresses stated below or to such other changed addresses
that the parties may have fixed by notice in accordance herewith.

If to the Company:

Regen
BioPharma, Inc.

4700
Sprint Street, Suite 304

La Mesa,
CA 91942

Attn:
David Koos, CEO

 

If to Employee:

Todd
S. Caven

8578
Terraceview Lane North

Maple
Grove, MN 55311

 

12. Waiver of Breach.

A
waiver by the Company or Employee of a breach of any provision of this Agreement by the other party shall
not operate or be construed as a waiver of any subsequent breach by the other party.

13. Entire
Agreement.

This
instrument contains the entire agreement of the parties with respect to the subject matter hereof and supersedes any
prior agreements of the parties with respect to the subject matter hereof. It may be changed only
by an agreement in writing signed by a party against whom enforcement of any waiver, change,
modification, extension or discharge is sought.

 14.
Applicable Law.

 The
terms and conditions of this Agreement shall be governed by and construed in accordance with the laws of the State or
California. Any action to enforce this Agreement shall be brought in the state courts located in San Diego County, State
of California.

IN WHITNESS WHEREOF,
the parties hereto have executed this Agreement as of the day and year first above written.

 

By:/s/David R. Koos

________________________ 

David R. Koos

Chief Executive Officer

 

 

By: /s/ Todd S. Caven

_________________________

Todd S. Caven 

    	 

    	 

    

Schedule
1.

Employer:
Regen BioPharma, Inc.

 

Location:
Company Headquarters and any remote offices

 

Description:

 

The Chief Financial
Officer day to day duties include:

 

		·	Coordinating
                                         the Company’s various fundraising initiatives.

		·	Overseeing
                                         the generation and maintenance of the Company’s financial records, including all
                                         audit and tax filings.

		·	Reviewing
                                         all key contracts that the Company enter into in order to maximize opportunity and minimize
                                         risk for the Company.

		·	Analyzing
                                         both Company and Industry/Peer Group Financial Data;

		·	Coordinating
                                         the Company’s risk management program. for the Company.

 

Position
Responsibilities:

 

		1.	Plan, develop, organize, implement and direct the Company fundraising program for all forms of capital.

 

		2.	Coordinate all aspects of the company’s financial records and regulatory reporting.

 

		3.	Review all key contracts and partnership agreements in order to assure adherence to Company policies and protocol.

 

		4.	Coordinate the development of an Industry/Peer Group database of key information/contacts in order to maximize the Company’s
strategic alliance opportunities.

 

		5.	Direct the development and implementation of the Company’s risk management program, including all types of insurance, adherence
to local, state or federal regulations, and internal risk management policies.

 

		6.	Perform other duties as required by the CEO. Perform other responsibilities as mandated by pertinent local, state or federal regulations.

 

    	 

    	 

    

Schedule
2.

Vesting
Schedule for signing shares

Signing Shares may
not be sold, transferred, assigned, pledged or otherwise encumbered or disposed of by Employee (“ Transfer Restriction”)
until 18 months of constant employment have expired from the date of the full execution of this agreement.Exhibit 10.2

EMPLOYMENT
AGREEMENT BETWEEN

REGEN
BIOPHARMA, INC.

AND

David
R. Koos 

THIS EMPLOYMENT
AGREEMENT (the "Agreement") dated as of February 11, 2015 is entered into between Regen BioPharma,
Inc., a Nevada corporation, (the "Company") and David R. Koos ("Employee").

 

WITNESSETH:

WHEREAS, Employee
and the Company desire to enter into an agreement providing for the employment by the Company of Employee
upon the terms provided herein.

REPRESENTATIONS AND WARRANTIES

 

A) Company
hereby represents and warrants to Employee as follows;

(i)
Corporate Existence of Company. Company:

(a) is a
corporation duly formed, validly existing and in good standing under the laws of the State of Nevada and

(b) has all requisite power
and authority, and has all governmental licenses, authorizations, consents and approvals necessary to execute and deliver this
Agreement and to consummate the transactions contemplated by this Agreement.

 

(ii) No
Conflicts. None of the execution, delivery and performance of this Agreement by Company, or the consummation
or the transactions contemplated hereby and thereby

 

(a)
constitutes or will constitute a violation of the organizational documents of Company,

 

(b)
constitutes or will constitute a breach or violation of, or a default (or an event which, with notice
or lapse of time or both, would constitute such a default) under, any indenture, mortgage,
deed of Company, loan agreement, lease or other agreement or instrument to which Company is a
party or by which Company or any of its properties may be bound,

 

(c)
violates or will violate any statute, law or regulation or any order, judgment, decree or injunction of any court
or Governmental Authority directed to Company or any of its properties in a proceeding to which
its property is or was a party.

 

(B) Employee hereby represents
and warrant to Company as follows:

(i) No Conflicts.
None of the execution, delivery and performance of this Agreement by Employee, or the consummation of the transactions contemplated
hereby and thereby

(a) constitutes or
will constitute a breach or violation of, or a default (or an event which, with notice or lapse of time or both, would constitute
such a default) under, any indenture, mortgage, deed of Trust, loan agreement, lease or other agreement or instrument to which
Employee is a party or by which Employee or any of its properties may be bound,

(b) violates or will
violate any statute, law or regulation or any order, judgment, decree or injunction of any court or Governmental Authority directed
to Employee or any of their properties in a proceeding to which its property is or was a party.

AGREEMENT:

NOW, THEREFORE, in consideration
of the foregoing and the mutual promises and agreements set forth herein, the parties hereto, intending to be legally bound, hereby
agree as follows:

1. Employment. During
the Employment Period (as defined in Section 2), the Company hereby employs Employee and Employee hereby accepts employment.

2. Term. The Term of
this Agreement shall commence on February 11, 2015 and shall expire on February 11, 2018 unless sooner terminated in accordance
with the provisions of Section 6 hereof; provided, however, that the term of this Agreement may be extended by mutual agreement.
The period from the commencement of the term of this Agreement to the date of its expiration or sooner termination shall be considered
to be the “Employment Period" hereunder.

3. Duties. Employee shall
be granted the title of Chief Executive Officer of the Company subject to the authority of the Company's Board of Directors (the
“BoD”). Employee shall perform such duties commensurate with his office and as directed the BoD such duties to include,
but not be limited to:

See Schedule 1.

During the Employment
Period, Employee shall perform his duties hereunder in a diligent manner, subject to the provisions of Schedule 1 of this Agreement;
devoting such amount of his business time, attention and efforts to the affairs of the Company within the scope of his employment
as is necessary for the proper rendition of such service and shall use his best efforts to promote the best interests of the Company.
Employee's services shall be rendered when and as required by the Board and in accordance with his instructions, direction and
control.

It is agreed that Employee
will only devote such time as to effectively conduct duties and responsibilities associated with this position pursuant to this
Agreement.

4. Compensation
Salary.

 

During the Employment Period, Company shall pay Employee salary at the rate of (i) $15,000 per month prorated for
any partial employment month ("Salary"). Salary shall be paid on a monthly basis (“Payday”) or, in the event
that Payday falls on a Saturday, Sunday or holiday, on the next business day. Salary may be paid, at the Company’s sole
discretion, either in

 

(a)        cash,
or

(b)        shares
of the Company’s common stock (“Stock Payment”)

 

Employee acknowledges
that any Stock Payments issued pursuant to this Agreement that are not registered pursuant to the Securities Act of 1933
shall constitute “restricted securities” as that term is defined in Rule 144 promulgated under the Securities Act
of 1933, and shall contain the following restrictive legend:

 

THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR SECURITIES LAWS
OF ANY STATE AND MAY NOT BE OFFERED, SOLD, ASSIGNED, PLEDGED, TRANSFERRED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN AVAILABLE
EXEMPTION FROM REGISTRATION UNDER THE ACT OR SUCH LAWS AND, IF REQUESTED BY THE COMPANY, UPON DELIVERY OF AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT THE PROPOSED TRANSFER IS EXEMPT FROM THE ACT OR SUCH LAWS.

 

The Company
may register any Stock Payment pursuant to the Securities Act of 1933, but is not obligated to do so pursuant to this Agreement.

 

5. Benefits.

a. During the Employment
Period, Employee shall be entitled to participation in any profit sharing plan, retirement plan, group life insurance plan or
other insurance plan, medical expense plan, medical and dental insurance and other benefit arrangements maintained by the Company
for its employees generally and, if applicable, their family members. In addition, Employee shall be entitled to two weeks paid
vacation (“Vacation”) subject to (i) the completion of 12 full months of employment pursuant to this Agreement and
(ii) having given fourteen days prior notice to the Company of Employee’s intent to Vacation.

b. Stock Compensation. 
Employee shall receive 9,000,000 newly issued common shares of the Company upon execution of this agreement (“Signing Shares”). 
The shares shall be subject to a vesting schedule (See Schedule 2)

Employee acknowledges
that any Signing Shares  issued pursuant to this Agreement will not be  registered pursuant to the Securities Act of
1933 , shall constitute “restricted securities” as that term is defined in Rule 144 promulgated under the Securities
Act of 1933 and shall contain the following restrictive legend:

THESE SECURITIES HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR SECURITIES LAWS OF ANY STATE AND
MAY NOT BE OFFERED, SOLD, ASSIGNED, PLEDGED, TRANSFERRED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION UNDER THE
ACT OR SUCH LAWS AND, IF REQUESTED BY THE COMPANY, UPON DELIVERY OF AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY
THAT THE PROPOSED TRANSFER IS EXEMPT FROM THE ACT OR SUCH LAWS.

6. Termination.

a.
Employee's employment hereunder shall terminate upon the earlier of:

(i) the expiration
of the Employment Period,

(ii) the death of
Employee,

(iii) the expiration
of a continuous period of thirty (30) calendar days during which Employee is unable to perform his material duties due to physical
or mental incapacity,

(iv) termination
by the Company due to “just cause,”

(v) termination by
Employee due to a material breach of this Agreement by the Company . The exercise of the right of the Company or Employee to terminate
this Agreement pursuant to clauses (iv) or (v) hereof, as the case may be, shall not abrogate the rights and remedies of the terminating
party in respect of the breach giving rise to such termination.

b.
"Just cause" hereunder shall be defined and limited to mean:

(i) Employee's failure
or refusal, as determined by either the BoD in his sole discretion, to perform specific directives of the BoD which are consistent
with the scope and nature of Employee's duties and responsibilities as set forth herein (including the duties described in Section
3), which failure or refusal continues after notice thereof and a reasonable time to cure; such reasonable time to be determined
by the BoD.

(ii) Employee's conviction
for a felony or any crime involving moral turpitude, fraud, or misrepresentation, or the presentation of proof satisfactory to
the BoD in the exercise of his reasonable judgment of Employee's misappropriation or embezzlement of funds or assets from the
Company;

(iii) any intentional
act having the purpose and effect of injuring the reputation, business or business relationships of the Company in any material
respect; and

(iv) any breach by
Employee of any material provision of this Agreement, including, without limitation, the restrictive covenants contained in Section
7 hereof.

c.
In the event of any dispute regarding the existence of Employee's incapacity hereunder, the matter will be resolved by the determination
of a physician qualified to practice medicine in California selected by the BoD. For this purpose, Employee will submit to appropriate
medical examinations.

d. If Employee's
employment hereunder is terminated pursuant to Section 6, the Company shall have no further obligations or liabilities hereunder.

7. Restrictive
Covenant.

a. Non-disclosure.
Employee has, and during the Employment Period will have, access to confidential information and trade secrets of the Company
and its subsidiaries (the "Confidential Information") that may include, among other things:

(i)
Financial information

(ii) Supply and services
information

(iii) Marketing information

(iv) Personnel information

(v) Customer information

(vi) Product information

(vii) The Company’s
procedures, systems, policies and processes of operation.

Employee shall
at all times during his employment by the Company and thereafter hold in strictest confidence any and all Confidential Information
that may have come or may come into Employee's possession or within Employee's knowledge. Employee agrees that neither he nor
any person or entity, directly or indirectly, controlled by or under common control with the Employee (an "Affiliate")will
for any reason, except in the course of performing his duties hereunder, for himself or any other person, use ordisclose to anyone,
exclusive of Company employees, agents, representatives, or independent consultants to the Company or any of its subsidiaries
or Affiliates of the Company, any Confidential Information; provided, however, that Employee may disclose Confidential Information
which (i) has become generally available to the public other than as a result of a breach of this Agreement by Employee or (ii)
Employee is compelled to disclose pursuant to subpoena or an order by a court competent jurisdiction; provided that, if Employee
is so required to disclose any Confidential Information pursuant to the foregoing clause (ii), Employee shall provide advance
written notice to the Company, to the extent possible, to allow the Company to seek an appropriate protective order therefore
(iii) Potential advisors, employees, or investors of the Company where there is a reasonable expectation of confidentiality. All
Confidential Information shall remain the Company's property and shall be returned (or, at the Company's option, destroyed) upon
the Company's written request.

b. Non-Solicitation
of Employees. Employee agrees that from the date hereof and continuing for a period of three years following the termination of
this Agreement for whatever reason (the "Non-Compete Period"), neither Employee nor any Affiliate of Employee will solicit
or hire for employment any officer, director or employee of the Company who was employed by the Company at any time within twelve
months prior to the act of solicitation.

c. Non-Competition.
Employee agrees that, other than with the approval of the BoD, which approval shall not be unreasonably withheld, during the Employment
Period, neither Employee nor any Affiliate of Employee will, directly or indirectly, become a shareholder, director, officer,
agent, partner or employee of, or otherwise hold any ownership interest in, any person, firm or entity engaged in any Competitive
Business (as defined below), engage as a sole proprietor in any Competitive Business, act as a consultant to or assist any of
the foregoing or otherwise engage or participate in any Competitive Business; provided, however, that the foregoing shall not
prohibit the ownership by Employee of less than ten percent (10%) of the outstanding shares of the stock of any corporation engaged
in any Competitive Business, which shares are regularly traded on a national securities exchange or in any over-the-counter market.
For the purpose hereof, "Competitive Business" means the ownership, operation, development, marketing of the services
related to, or management of cellular therapeutics within the United States.

d.
Consideration, Relief, Reformation; Severability. The Company has specifically bargained for the covenants set forth in this
Section 6 in consideration for the compensation, experience, and information that Employee will gain or receive in connection
with his employment by the Company. Employee agrees that the covenants set forth herein will not preclude Employee from
engaging in any lawful profession, trade or business or from being gainfully employed necessary to provide Employee, his
family members and dependents a standard of living to which he and they have been accustomed and may expect. Employee
acknowledges and agrees that the restrictive covenants in this Section 6 have been specifically negotiated, are reasonable in
all respects, including, without limitation, their geographic scope and duration, and may be enforced by specific performance
or otherwise. Employee shall not raise any issue of reasonableness as a defense in any proceeding to enforce any of such
covenants. Notwithstanding the foregoing, in the event that a covenant included in this Agreement shall be deemed by any
court to be unreasonably broad in any respect, it shall be modified or limited in its geographic scope, duration or otherwise
to the extent necessary to make it reasonable while preserving its restrictive nature to the maximum degree possible and
shall be enforced accordingly; provided however, that if, notwithstanding the foregoing, a court of competent jurisdiction
shall hold any of the covenants contained in Sections 7 (a), (b) or (c) to be unenforceable (as so modified), then the
unenforceable covenant shall be deemed eliminated from the provisions of this Agreement for the purpose of those proceedings
to the extent necessary to permit the remaining covenants to be enforced so that the validity, legality or enforceability of
the remaining provisions of this Agreement shall not be affected thereby.

8. Developments.

Employee hereby
assigns to the Company his entire right, title and interest in all know how, discoveries and improvements,
customer lists, trade secrets and ideas, writings and copyrightable material, which may be conceived by Employee
or developed or acquired by him during the term of this Agreement, which may pertain directly to the Company's business
and were developed with Company resources. Employee agrees to promptly and fully disclose in writing all such developments. Employee
will, upon the Company's request, execute, acknowledge and deliver to the Company all instruments
and do all other acts which are necessary or desirable to entitle the Company to all rights in the foregoing
and enable the Company to file and prosecute applications for, and to acquire, maintain and enforce all letters, trademark
registrations or copyrights with respect to the foregoing in all countries.

9. Remedies.

Employee
acknowledges that any material breach of this Agreement will cause irreparable harm to the Company, that such harm will be difficult
if not impossible to ascertain, and that the Company shall be entitled to equitable relief, including injunction, against
any actual or threatened breach hereof, without bond and without liability should such relief be denied, modified or vacated.
Neither the right to obtain such relief nor the obtaining of such relief shall be exclusive of or preclude the
Company from any other remedy.

10.
Legal Counsel.

Employee
acknowledges that Employee has carefully read this Agreement and understands all of the terms hereof and that Employee
has been given the opportunity to discuss this Agreement with Employee's private legal counsel and
has availed himself of that opportunity to the extent Employee wishes to do so.

11. Notices.

All
notices, requests and other communications under this Agreement shall be in writing and shall be deemed to have been received
five business days after having been deposited in the United States Mail and enclosed in a registered or certified post-paid
envelope; one day after having been sent by overnight courier on a business day or otherwise at the open of
business on the next succeeding business day; when personally delivered or sent by facsimile communications equipment
of the sending party on a business day or otherwise at the open of business on the next succeeding business day; and, in
each case, addressed to the respective parties at the addresses stated below or to such other changed addresses
that the parties may have fixed by notice in accordance herewith.

If to the Company:

Regen
BioPharma, Inc.

4700
Sprint Street, Suite 304

La Mesa,
CA 91942

Attn:
David Koos, CEO

 

If to Employee:

David
R. Koos

C/O
Regen BioPharma

4700
Spring Street, Suite 304

La
Mesa, CA 91942

 

12. Waiver of Breach.

A
waiver by the Company or Employee of a breach of any provision of this Agreement by the other party shall
not operate or be construed as a waiver of any subsequent breach by the other party.

13. Entire
Agreement.

This
instrument contains the entire agreement of the parties with respect to the subject matter hereof and supersedes any
prior agreements of the parties with respect to the subject matter hereof. It may be changed only
by an agreement in writing signed by a party against whom enforcement of any waiver, change,
modification, extension or discharge is sought.

 14.
Applicable Law.

 The
terms and conditions of this Agreement shall be governed by and construed in accordance with the laws of the State or
California. Any action to enforce this Agreement shall be brought in the state courts located in San Diego County, State
of California.

IN WHITNESS WHEREOF,
the parties hereto have executed this Agreement as of the day and year first above written.

 

By:/s/David R. Koos

________________________ 

David R. Koos

Chief Executive Officer

 

 

By: David R. Koos

_________________________

David R. Koos

Employee 

    	 

    	 

    

Schedule
1.

Employer:
Regen BioPharma, Inc.

 

Location:
Company Headquarters and any remote offices

 

Description:

 

The Chief Executive
Officer day to day duties include:

 

		·	Coordinating
                                         the Company’s various fundraising initiatives.

		·	Overseeing
                                         the generation and maintenance of the Company’s financial records, including all
                                         audit and tax filings.

		·	Reviewing
                                         and executing all key contracts that the Company enter into in order to maximize opportunity
                                         and minimize risk for the Company.

		·	Analyzing
                                         both Company and Industry/Peer Group Financial Data;

		·	Coordinating
                                         the Company’s risk management program. for the Company.

		·	Management
                                         of the overall company and all its employees and consultants

		·	Set
                                         corporate policies, procedures and protocols

		·	Legal
                                         compliance oversight

		·	Corporate
                                         planning and implementation

		·	Corporate
                                         governance

		·	Develops
                                         public image and corporate brand

 

Position
Responsibilities:

 

		1.	This
                                         position reports directly to the Company’s Board of Directors and is solely responsible
                                         for implementing its policies, procedures and other such directives.

 

		2.	Provides
                                         oversight for the Company’s Board of Directors in all aspects of corporate governance.
                                         

 

		3.	Reviews
                                         and executes all key contracts and partnership agreements and assigns appropriate employees
                                         and consultants to assist in the vetting of such agreements.

 

		4.	Coordinate
                                         the development of an Industry/Peer Group database of key information/contacts in order
                                         to maximize the Company’s strategic alliance opportunities.

 

		5.	Oversees
                                         the development and implementation of the Company’s risk management program, including
                                         all types of insurance, adherence to local, state or federal regulations, and internal
                                         risk management policies.

 

		6.	Perform
                                         other duties as required by the Board of Directors. 

 

		7.	Perform
                                         other responsibilities as mandated by pertinent local, state or federal regulations.

    	 

    	 

    

Schedule
2.

Vesting
Schedule for signing shares

Signing Shares may
not be sold, transferred, assigned, pledged or otherwise encumbered or disposed of by Employee (“Transfer Restriction”)
until 18 months of constant employment have expired from the date of the full execution of this agreement.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00240-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00240-of-00352.parquet"}]]